A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)

被引：0
|
作者：
Kuhlmann, J. D. [1 ,2 ]
Klotz, B. M. [1 ,2 ]
Link, T. [1 ,2 ]
Wimberger, P. [1 ,2 ]
机构：
[1] Tech Univ Dresden, Dept Gynecol & Obstet, Med Fac, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1769870
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
61
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [21] APPLICATION VALUE OF HE4, CA125 AND ROMA IN DIAGNOSIS OF THE OVARIAN CANCER
    Sun, Wenchao
    Wang, Jinfang
    Liu, Lubin
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1765 - 1769
  • [22] HE4 combined with CA125: favorable screening tool for ovarian cancer
    Ghasemi, Nasrin
    Ghobadzadeh, Samira
    Zahraei, Mahnaz
    Mohammadpour, Hemn
    Bahrami, Salahadin
    Ganje, Mohammad Bakhshi
    Rajabi, Shokoh
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [23] Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
    Barr, Chloe E.
    Njoku, Kelechi
    Owens, Gemma L.
    Crosbie, Emma J.
    CANCERS, 2023, 15 (04)
  • [24] Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
    Schummer, Michel
    Drescher, Charles
    Forrest, Robin
    Gough, Shirley
    Thorpe, Jason
    Hellstroem, Ingegerd
    Hellstroem, Karl Erik
    Urban, Nicole
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 65 - 69
  • [25] INCORPORATING HE4 AND CA125 INTO AN ENDOMETRIAL CANCER SURGICAL REFERRAL ALGORITHM
    Kalogera, E.
    Weaver, A. L.
    Bakkum-Gamez, J. N.
    Cliby, W. A.
    Mariani, A.
    Podratz, K. C.
    Dowdy, S. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1510 - 1511
  • [26] Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
    Rong, Yan
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [27] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Jorge A. Alegría-Baños
    José C. Jiménez-López
    Arely Vergara-Castañeda
    David F. Cantú de León
    Alejandro Mohar-Betancourt
    Delia Pérez-Montiel
    Gisela Sánchez-Domínguez
    Mariana García-Villarejo
    César Olivares-Pérez
    Ángel Hernández-Constantino
    Acitlalin González-Santiago
    Miguel Clara-Altamirano
    Liz Arela-Quispe
    Diddier Prada-Ortega
    Journal of Ovarian Research, 14
  • [28] Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
    Yan Rong
    Li Li
    Journal of Ovarian Research, 14
  • [29] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Alegria-Banos, Jorge A.
    Jimenez-Lopez, Jose C.
    Vergara-Castaneda, Arely
    Cantu de Leon, David F.
    Mohar-Betancourt, Alejandro
    Perez-Montiel, Delia
    Sanchez-Dominguez, Gisela
    Garcia-Villarejo, Mariana
    Olivares-Perez, Cesar
    Hernandez-Constantino, Angel
    Gonzalez-Santiago, Acitlalin
    Clara-Altamirano, Miguel
    Arela-Quispe, Liz
    Prada-Ortega, Diddier
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [30] Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer
    Tian, Yun
    Li, Xiabing
    Zhang, Hongjian
    Wang, Yaping
    Li, Hongyu
    Qin, Qiaohong
    FRONTIERS IN ONCOLOGY, 2024, 14
12345